SNWV (SANUWAVE Health) Beta: 0.3999 (As of Jun. 25, 2026)


SNWV SANUWAVE Health Inc SNWV
38 GF Score
Price $8.57
GF Value $11.86
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is SANUWAVE Health Beta?

SANUWAVE Health SNWV +4.39% 38 Beta is 0.3999 as of Jun. 25, 2026. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.86 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), SANUWAVE Health's Beta is 0.3999.


SANUWAVE Health  (NAS:SNWV) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


SANUWAVE Health Beta Related Terms


SANUWAVE Health Beta Historical Data

* Premium members only.

The historical data trend for SANUWAVE Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SANUWAVE Health Beta Chart

SANUWAVE Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.97 1.48 1.78 1.24

SANUWAVE Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.18 1.42 1.24 0.94

SNWV vs QTRX, CVRX, NNOX: Beta Comparison

For the Medical Devices subindustry, SANUWAVE Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Beta distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Beta falls into.


SNWV
38GF Score
SANUWAVE Health Inc SNWV
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SANUWAVE Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3999 mean?
SANUWAVE Health (SNWV) has a Beta of 0.3999 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for SANUWAVE Health and its competitors.
Is SANUWAVE Health's Beta too high?
SANUWAVE Health's current Beta is 0.3999. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Beta compare to QTRX and CVRX?
SANUWAVE Health's Beta of 0.3999 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for SANUWAVE Health and its competitors. SANUWAVE Health's current Beta is 0.3999. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.86, compared to a current price of $8.57 — trading 27.7% below its estimated fair value. The current Beta is 0.3999. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Beta is 0.3999 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $8.57 is trading 27.7% below its estimated GF Value™ of $11.86. GuruFocus considers SANUWAVE Health to be Modestly Undervalued.

Key valuation signals for SNWV:

  • Beta: 0.3999
  • GF Value™: $11.86 vs. price of $8.57 (27.7% below fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SANUWAVE Health Business Description

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score

Get the complete analysis for SNWV

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.57
Price
$11.86
GF Value